Joy Milne, a woman with an extraordinary sense of smell, discovered she could detect a distinct odor from her husband years before his Parkinson's diagnosis. This led researchers to validate her ability and identify molecular changes in skin secretions as potential early biomarkers for Parkinson's disease, even before motor symptoms appear.
In this episode of The Daily, the unique story behind Joy Milne's discovery is explored, along with the scientific efforts to develop a simple, non-invasive test that could enable earlier interventions for Parkinson's. While promising, experts grapple with the ethical implications of disclosing one's risk for a neurodegenerative condition before symptoms arise.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Joy Milne was born with an incredibly acute sense of smell that enabled her to detect an unusual musky odor on her husband, Les, years before he was diagnosed with Parkinson's disease. According to Joy, this scent signified a fundamental shift in his identity. Her ability to identify Parkinson's in others by its distinct odor alone has profound implications for early diagnosis and understanding the condition.
Joy felt that the medical community often dismissed or misunderstood the psychological and behavioral symptoms of Parkinson's. Her advocacy stemmed from the challenges of caring for Les, who faced misdiagnoses and lack of awareness about the disease's full spectrum of symptoms beyond movement issues. Joy believes an earlier diagnosis could have mitigated much of the pain they endured and suggests her late mother-in-law's psychiatric issues were likely undiagnosed Parkinson's manifestations.
Initially met with skepticism, Joy's claims about detecting Parkinson's through smell led researchers at the University of Edinburgh to validate her abilities. Further studies revealed that the distinctive odor seemed to originate from changes in sebum, a lipid-rich skin secretion. Chemical analysis identified higher concentrations of icosane, octadecanol, and hypuric acid in Parkinson's patients' sebum, indicating disruptions in cellular pathways. These compounds were also found in individuals with pre-manifest Parkinson's, suggesting their potential as early biomarkers.
Inspired by Joy Milne's discovery, researchers envision a simple, non-invasive swab test to detect these molecular signatures, enabling earlier interventions to prevent or delay Parkinson's progression before motor symptoms appear. However, Petkoff notes the ethical dilemma of informing asymptomatic individuals that they may develop a devastating neurodegenerative disease. Experts grapple with balancing the benefits of early detection against the psychological burden and social implications, emphasizing the need for longitudinal studies and informed consent.
1-Page Summary
Joy Milne's unique olfactory abilities, deeply shaped by her family history and personal experiences, hold the key to her profound connection with Parkinson's disease—a condition she detected in her husband years before formal diagnosis.
Joy Milne possesses an acute sense of smell, which has necessitated significant adjustments in her life to avoid overpowering scents. She inherited this heightened sense of smell from her maternal lineage, particularly her grandmother, a fellow hyperosmic. As a child, her grandmother encouraged her to hone her olfactory abilities, setting the stage for a gift that would later emerge as instrumental in identifying her husband's serious health condition.
Joy adored her husband Les's natural smell, which was a comforting mix of salt, musk, and leather from the soap he used. But one evening, Joy detected a new and persistent musty scent on Les, which signaled a fundamental shift in his identity for her. This unsettling change was a point of alienation, marking the beginning of what would later be understood as a connection to Parkinson's disease.
Joy's extraordinary sense of smell became inseparable from her relationship with Les, and ultimately her life's journey with Parkinson's disease. She noticed that everyone she met with Parkinson's had the same peculiar, musty odor that she had detected on her husband years before he was diagnosed. Her ability to identify Parkinson's by scent alone has tremendous implications for early diagnosis and understanding of the disease.
Joy Milne lives alone after Les's death in 2015 from Parkinson's. Her spice collection, representative of her love for intense scents, perhaps offers some solace. However, her experiences have left her with a heavy heart, especially toward the medical community's response to Parkinson's disease.
She experienced frustration in communicating with medical professionals who often dismissed the psychological symptoms associated with Parkinson's, symptoms she found more challenging to manage than the physical ones. Les's own struggle with dementia and sexual compulsion highlighted the complexity of the disease that extended far beyond movement issues—an understanding that Joy felt was lacking among medical practitioners.
Her insistence on recognizing th ...
Joy Milne's extraordinary sense of smell and her personal experience with Parkinson's disease
The unique ability of Joy Milne to smell Parkinson's disease has led to remarkable scientific studies that could revolutionize early diagnosis.
Joy Milne's realization that Parkinson's disease might have a detectable odor came when she attended a meeting of local Parkinson's patients and noticed they all shared a distinct smell, similar to the one her husband had had for years. Despite initial skepticism, her claims led to scientific investigation.
Researchers conducted tests with Joy that showed she could unequivocally distinguish Parkinson's patients from those without the disease based on smell alone. Joy participated in a small pilot study in Edinburgh, where she successfully identified Parkinson's patients by their scent, which led to further funding for a full study on Joy's olfactory ability and the chemical components of Parkinson's.
After media attention, more people came forward reporting they too could smell Parkinson's. The odor, described as musty, oily, or like sour milk, had been noticed by individuals before a formal medical diagnosis. Nurses at NHS clinics in England and Scotland collected sebum samples from Parkinson's patients and sent them to the researchers for Joy to smell and chemical analysis. The odor that Joy detected concentrated at the neckline; researchers speculated that it came from sebum, a substance not previously considered for disease detection.
Further research included participants who wore t-shirts for scent collection. Joy could accurately identify Parkinson's patients and their sample counterparts. There was one mislabeled control t-shirt that later turned out to belong to a person who was diagnosed with Parkin ...
The scientific discovery and research into the chemical signatures of Parkinson's disease in sebum
Researchers are currently developing an early diagnostic test for Parkinson's disease through the understanding of molecular signatures in sebum. This non-invasive test could screen for the disease before motor symptoms appear, presenting a "holy grail" for Parkinson's research.
Inspired by reports, including Joy Milne's ability to smell Parkinson's, researchers are considering the use of sebum tests for early detection of Parkinson's disease. A simple swab test could enable earlier interventions that might prevent or delay the disease's progression. The company Seebomics is looking to commercialize a sebum-based test, and such early-stage identification methods could help prevent or delay classical symptoms of Parkinson's since the disease is typically diagnosed based on its characteristic motor symptoms after significant neuron damage has occurred.
Robert Petkoff discusses the future potential of a sebum swab suggesting Parkinson's in a patient with no outward signs. Early treatment with neuroprotective drugs following more invasive testing could result from it. This novel diagnostic approach would be key to making significant strides in addressing the disease.
The Michael J. Fox Foundation for Parkinson's Research has invested significantly in the search for such a biomarker. Unfortunately, one potential test, involving a spinal tap, has limited utility due to its invasive nature. Sebum analysis could, alternatively, be part of a suite of tests to create a risk profile for Parkinson's.
The excitement for a potential diagnostic test is tempered by the ethical considerations it raises.
The potential development of an early diagnostic test for Parkinson's and the associated ethical considerations
Download the Shortform Chrome extension for your browser